fox29.com
50%
812
Moderna begins clinical trials for booster doses of COVID-19 vaccine to combat South Africa variant
CAMBRIDGE, Mass. - Moderna announced that it has shipped booster doses of its COVID-19 vaccine booster designed specifically to offer better protection against the South Africa coronavirus variant to the National Institutes of Health (NIH) for a Phase 1 clinical trial. "While initial data confirms that the Moderna COVID-19 Vaccine (mRNA-1273) provides neutralizing activity against variants of concern, out of an abundance of caution, Moderna is pursuing two strategies against these variants," Moderna wrote in a press release on Wednesday.The company said that initial data confirms that its already-distributed coronavirus vaccine provides neutralizing activity for concerning variants.But Moderna said out of an abundance of caution, the NIH